Cart
sales@molnova.com
Brigimadlin
CAS No. 2095116-40-6
Brigimadlin( —— )
Catalog No. M36316 CAS No. 2095116-40-6
Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 354 | In Stock |
|
| 5MG | 272 | In Stock |
|
| 10MG | 372 | In Stock |
|
| 25MG | 611 | In Stock |
|
| 50MG | 909 | In Stock |
|
| 100MG | 1358 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrigimadlin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase
-
DescriptionBrigimadlin (BI 907828) is an E3 ubiquitin-protein ligase MDM-2 inhibitor, preventing MDM-2 from negatively regulating the tumor suppressor p53. Brigimadlin can be used for antineoplastic research.
-
In VitroCell Viability Assay Cell Line:BT48, BT50, BT67, BT69, BT89, BT94 Concentration:0-10 nM Incubation Time:48 h Result:IC50: 58.5, 21.1, 37.9, 89.8, 16.7, 46.8 pM.Western Blot Analysis Cell Line:BT48, BT67, BT73 cells Concentration:0-50 nM Incubation Time:48 h Result:Upregulated p21 and PUMA, and increased cleaved PARP level.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetMDM2-p53
-
RecptorMdm2 | p53
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2095116-40-6
-
Formula Weight591.46
-
Molecular FormulaC31H25Cl2FN4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1[C@@]2([C@H]([C@]3([C@@]1(CC=4N3N=C5C4C=CC(C(O)=O)=C5C)[H])[H])C6=C(F)C(Cl)=CC=C6)C=7C(NC2=O)=CC(Cl)=CC7)C8CC8
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gollner Andreas, et al. Preparation of spiroindolepyrrolidinone derivatives for use as MDM2-p53 inhibitors: World Intellectual Property Organization, WO2017060431. 2017-04-13.
molnova catalog
related products
-
UC2288
UC2288 is a relatively selective p21 attenuator which is synthesized based Sorafenib. UC2288 attenuates p21 protein levels with minimal effect on p21 protein stability.
-
NSC-59984
A small molecule that both destabilize mutant p53 and restores wild-type p53 pathway in cancer cells.
-
COTI-2
COTI-2 (COTI2) is an orally available thiosemicarbazone that may act on mutant forms of p53 and PI3K/AKT/mTOR pathway.
